BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 24382809)

  • 1. Insertion of proteolipid protein into oligodendrocyte mitochondria regulates extracellular pH and adenosine triphosphate.
    Appikatla S; Bessert D; Lee I; Hüttemann M; Mullins C; Somayajulu-Nitu M; Yao F; Skoff RP
    Glia; 2014 Mar; 62(3):356-73. PubMed ID: 24382809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insertion of proteolipid protein into mitochondria but not DM20 regulates metabolism of cells.
    Somayajulu M; Bessert DA; Hüttemann M; Sohi J; Kamholz J; Skoff RP
    Neurosci Lett; 2018 Jun; 678():90-98. PubMed ID: 29729355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PLP overexpression perturbs myelin protein composition and myelination in a mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Kirkham D; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2007 Mar; 55(4):341-51. PubMed ID: 17133418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress and mitochondrial dynamics malfunction are linked in Pelizaeus-Merzbacher disease.
    Ruiz M; Bégou M; Launay N; Ranea-Robles P; Bianchi P; López-Erauskin J; Morató L; Guilera C; Petit B; Vaurs-Barriere C; Guéret-Gonthier C; Bonnet-Dupeyron MN; Fourcade S; Auwerx J; Boespflug-Tanguy O; Pujol A
    Brain Pathol; 2018 Sep; 28(5):611-630. PubMed ID: 29027761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Plp1 gene expression leads to massive microglial cell activation and inflammation throughout the brain.
    Tatar CL; Appikatla S; Bessert DA; Paintlia AS; Singh I; Skoff RP
    ASN Neuro; 2010 Sep; 2(4):e00043. PubMed ID: 20885931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically relevant intronic splicing enhancer mutation in myelin proteolipid protein leads to progressive microglia and astrocyte activation in white and gray matter regions of the brain.
    Bachstetter AD; Webster SJ; Van Eldik LJ; Cambi F
    J Neuroinflammation; 2013 Dec; 10():146. PubMed ID: 24314267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gait abnormalities and progressive myelin degeneration in a new murine model of Pelizaeus-Merzbacher disease with tandem genomic duplication.
    Clark K; Sakowski L; Sperle K; Banser L; Landel CP; Bessert DA; Skoff RP; Hobson GM
    J Neurosci; 2013 Jul; 33(29):11788-99. PubMed ID: 23864668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A common mechanism of PLP/DM20 misfolding causes cysteine-mediated endoplasmic reticulum retention in oligodendrocytes and Pelizaeus-Merzbacher disease.
    Dhaunchak AS; Nave KA
    Proc Natl Acad Sci U S A; 2007 Nov; 104(45):17813-8. PubMed ID: 17962415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of a splicing enhancer disrupts PLP1/DM20 ratio and myelin stability.
    Wang E; Dimova N; Sperle K; Huang Z; Lock L; McCulloch MC; Edgar JM; Hobson GM; Cambi F
    Exp Neurol; 2008 Dec; 214(2):322-30. PubMed ID: 18835559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perturbed interactions of mutant proteolipid protein/DM20 with cholesterol and lipid rafts in oligodendroglia: implications for dysmyelination in spastic paraplegia.
    Krämer-Albers EM; Gehrig-Burger K; Thiele C; Trotter J; Nave KA
    J Neurosci; 2006 Nov; 26(45):11743-52. PubMed ID: 17093095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of proteolipid protein rescues Pelizaeus-Merzbacher disease.
    Elitt MS; Barbar L; Shick HE; Powers BE; Maeno-Hikichi Y; Madhavan M; Allan KC; Nawash BS; Gevorgyan AS; Hung S; Nevin ZS; Olsen HE; Hitomi M; Schlatzer DM; Zhao HT; Swayze A; LePage DF; Jiang W; Conlon RA; Rigo F; Tesar PJ
    Nature; 2020 Sep; 585(7825):397-403. PubMed ID: 32610343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLP1 gene duplication causes overexpression and alteration of the PLP/DM20 splicing balance in fibroblasts from Pelizaeus-Merzbacher disease patients.
    Regis S; Grossi S; Corsolini F; Biancheri R; Filocamo M
    Biochim Biophys Acta; 2009 Jun; 1792(6):548-54. PubMed ID: 19376225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal loss in Pelizaeus-Merzbacher disease differs in various mutations of the proteolipid protein 1.
    Sima AA; Pierson CR; Woltjer RL; Hobson GM; Golden JA; Kupsky WJ; Schauer GM; Bird TD; Skoff RP; Garbern JY
    Acta Neuropathol; 2009 Oct; 118(4):531-9. PubMed ID: 19562355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PMD patient mutations reveal a long-distance intronic interaction that regulates PLP1/DM20 alternative splicing.
    Taube JR; Sperle K; Banser L; Seeman P; Cavan BC; Garbern JY; Hobson GM
    Hum Mol Genet; 2014 Oct; 23(20):5464-78. PubMed ID: 24890387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLP1 splicing abnormalities identified in Pelizaeus-Merzbacher disease and SPG2 fibroblasts are associated with different types of mutations.
    Bonnet-Dupeyron MN; Combes P; Santander P; Cailloux F; Boespflug-Tanguy O; Vaurs-Barrière C
    Hum Mutat; 2008 Aug; 29(8):1028-36. PubMed ID: 18470932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease.
    Karim SA; Barrie JA; McCulloch MC; Montague P; Edgar JM; Iden DL; Anderson TJ; Nave KA; Griffiths IR; McLaughlin M
    Glia; 2010 Nov; 58(14):1727-38. PubMed ID: 20629189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural stem cells restore myelin in a demyelinating model of Pelizaeus-Merzbacher disease.
    Gruenenfelder FI; McLaughlin M; Griffiths IR; Garbern J; Thomson G; Kuzman P; Barrie JA; McCulloch ML; Penderis J; Stassart R; Nave KA; Edgar JM
    Brain; 2020 May; 143(5):1383-1399. PubMed ID: 32419025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelizaeus-Merzbacher disease: on the cusp of myelin medicine.
    Elitt MS; Tesar PJ
    Trends Mol Med; 2024 May; 30(5):459-470. PubMed ID: 38582621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of ER stress in dysmyelination of Pelizaeus-Merzbacher Disease with PLP1 missense mutations shown by iPSC-derived oligodendrocytes.
    Numasawa-Kuroiwa Y; Okada Y; Shibata S; Kishi N; Akamatsu W; Shoji M; Nakanishi A; Oyama M; Osaka H; Inoue K; Takahashi K; Yamanaka S; Kosaki K; Takahashi T; Okano H
    Stem Cell Reports; 2014 May; 2(5):648-61. PubMed ID: 24936452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pathologic findings in patients with Pelizaeus-Merzbacher disease.
    Laukka JJ; Kamholz J; Bessert D; Skoff RP
    Neurosci Lett; 2016 Aug; 627():222-32. PubMed ID: 27222925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.